D.L. Carlson Investment Group’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$7.87M Buy
6,558
+1,575
+32% +$1.61M 1.25% 19
2026
Q1
$4.58M Buy
4,983
+2,333
+88% +$2.37M 0.79% 35
2025
Q4
$2.85M Sell
2,650
-18
-0.7% -$17.2K 0.48% 60
2025
Q3
$2.04M Buy
2,668
+182
+7% +$135K 0.34% 74
2025
Q2
$1.94M Sell
2,486
-392
-14% -$305K 0.35% 73
2025
Q1
$2.38M Sell
2,878
-262
-8% -$218K 0.46% 65
2024
Q4
$2.42M Sell
3,140
-35
-1% -$29K 0.43% 64
2024
Q3
$2.81M Sell
3,175
-3,240
-51% -$2.91M 0.51% 59
2024
Q2
$5.81M Sell
6,415
-45
-0.7% -$36K 1.12% 17
2024
Q1
$5.03M Sell
6,460
-160
-2% -$114K 0.98% 28
2023
Q4
$5.02M Buy
6,620
+6,128
+1,246% +$3.58M 1.02% 25
2023
Q3
$264K Buy
+492
New +$254K 0.05% 117

Other funds holding LLY

D.L. Carlson Investment Group's LLY Position: Q2 2026 in Review

D.L. Carlson Investment Group increased its Eli Lilly (LLY) stake by 32% in Q2 2026, buying an estimated $1.61M and bringing the position to 6,558 shares worth $7.87M. The position accounts for 1.25% of the portfolio, ranked #19.

D.L. Carlson Investment Group first reported a position in LLY in Q3 2023 and has held it in 12 quarters since. 4,642 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • D.L. Carlson Investment Group held 6,558 shares of Eli Lilly worth $7.87M as of Q2 2026.
  • D.L. Carlson Investment Group bought 1,575 Eli Lilly shares in Q2 2026, an estimated $1.61M.
  • Eli Lilly made up 1.25% of D.L. Carlson Investment Group's portfolio in Q2 2026, its #19 holding.
  • D.L. Carlson Investment Group first reported a position in Eli Lilly in Q3 2023 and has held it in 12 quarters since.
  • 4,642 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on D.L. Carlson Investment Group's 13F filing for Q2 2026, filed 11 Aug 2026.